Flt3 Internal Tandem Duplication and P-Glycoprotein Functionality in 171 Patients With Acute Myeloid Leukemia

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-0641
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Improved FLT3 Internal Tandem Duplication PCR Assay Predicts Outcome After Allogeneic Transplant for Acute Myeloid Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Prevalence of FMS-like Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD+) in De Novo Acute Myeloid Leukemia Patients Categorized According to Cytogenetic Risk

Sao Paulo Medical Journal
Medicine
2009English

Radius: Midostaurin (Mido) Plus Standard of Care (SOC) After Allogeneic Stem Cell Transplant (alloSCT) in Patients (Pts) With FLT3-Internal Tandem Duplication (ITD)–Mutated Acute Myeloid Leukemia (AML)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Hybridization Capture-Based Next Generation Sequencing Reliably Detects FLT3 Mutations and Classifies FLT3-internal Tandem Duplication Allelic Ratio in Acute Myeloid Leukemia: A Comparative Study to Standard Fragment Analysis

Modern Pathology
Forensic MedicinePathology
2019English

FLT3-TKD Mutation in Childhood Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

Successful Treatment of Post-Transplant Relapsed Acute Myeloid Leukemia With FLT3 Internal Tandem Duplication Using the Combination of Induction Chemotherapy, Donor Lymphocyte Infusion, Sorafenib and Azacitidine. Report of Three Cases

Einstein (São Paulo, Brazil)
Medicine
2017English

Novel Mutations in the FLT3 Gene in Adult Patients With Refractory Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2011English

The FLT3 Internal Tandem Duplication Mutation Is a Secondary Target of the Aurora B Kinase Inhibitor AZD1152-HQPA in Acute Myelogenous Leukemia Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy